About
Transforming Detection. Improving Lives.TM
Vigilant Biosciences is a leading innovator and developer of solutions that aid in the early detection of oral and oropharyngeal cancer. Our point–of–care solution is simple, accurate† and cost–effective–empowering clinicians to improve potential outcomes through earlier intervention.
Vigilant Biosciences’ innovative BeVigilant™ RAPID Test is based on patented technology that detects specific protein markers clinically shown to be associated with early stage cancers, potentially even prior to visual or physical indicators. The BeVigilant RAPID Test is CE Marked and available in select markets outside the United States.
We are Vigilant Biosciences,
and we’re changing lives together through the transformation of early detection of oral cancer.
Our Mission
To save lives by providing a more effective, early detection solution for oral and oropharyngeal cancer.
Our Promise
We relentlessly pursue life-changing answers to be the leading innovator and developer of solutions that aid clinicians in improving potential outcomes through earlier detection of oral and oropharyngeal cancer.
Our Principles
Advanced Science & Technology
Integrity
Improving Quality of Life
Leadership & Expertise
Our Mission
To save lives by providing a more effective, early detection solution for oral and oropharyngeal cancer.
Our Promise
We relentlessly pursue life-changing answers to be the leading innovator and developer of solutions that aid clinicians in improving potential outcomes through earlier detection of oral and oropharyngeal cancer.
Our Principles
Advanced Science & Technology
Integrity
Improving Quality of Life
Leadership & Expertise
†Clinical Data on File
© 2020 Vigilant Biosciences